Desh Rakshak Aushdhalaya Ltd.

7.29 ▼0%

08 April 2024, 04:01:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.deshrakshak.in
Market Cap 3.24 Cr.
Enterprise Value(EV) 7.43 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.96 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 7.61 Trailing Twelve Months Ending 2023-12
Industry PE 41.03 Trailing Twelve Months Ending 2023-12
Book Value / Share 20.70 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.35 Calculated using Price: 7.29
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.44 Cr. 4,438,324 Shares
FaceValue 10
About Desh Rakshak Aushdhalaya Ltd.
The company is the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by its Ancient Seers & Sages. The medicines are categorized into Patent & Proprietary (Classical) Medicines. The company is currently manufacturing around 400 products (Patent and Classical mix). And all these medicines are manufactured as per the prescribed norms and standards of the Indian Government.

Desh Rakshak Aushdhalaya Ltd. Delivery

Delivered Qty
Traded Qty

Desh Rakshak Aushdhalaya Ltd. Performance

1 Day
1 Week
1 Month
+4.89%
3 Month
+4.89%
6 Month
+21.30%
1 Year
+40.19%
2 Year
+69.53%
5 Year
+78.24%
10 Year
-16.21%

Desh Rakshak Aushdhalaya Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.37 4.36 4.03 3.9 4.4 3.83 5.05 5.49 4.54
Return on Capital Employed (%) 2.54 5.98 5.33 5.54 5.99 5.77 6.69 6.44 6.7
Return on Assets (%) 0.26 2.96 2.78 2.69 3.01 2.56 3.12 3.13 2.54

Desh Rakshak Aushdhalaya Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 7 7 7 8 8 8 9 9 9 9
Non Curr. Liab. 1 1 1 1 1 2 3 4 4 4
Curr. Liab. 2 2 2 2 2 2 3 3 3 2
Minority Int.
Equity & Liab. 10 10 10 11 11 12 15 16 16 16
Non Curr. Assets 5 6 6 7 7 8 9 11 11 10
Curr. Assets 5 4 4 4 4 4 5 6 5 5
Misc. Exp. not W/O
Total Assets 10 10 10 11 11 12 15 16 16 16

Desh Rakshak Aushdhalaya Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 4 5 5 5 6 5 7 6 6 5
Other Income 0 0 0 0 0 0 0 0
Total Income 4 5 5 5 6 5 7 6 6 5
Total Expenditure -4 -4 -4 -4 -5 -4 -6 -5 -5 -4
PBIDT 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 1 1 1 1 1 1 1 1 1

Desh Rakshak Aushdhalaya Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 1 0 0 -1 1 1 0 0
Cash Fr. Inv. 0 0 -1 -1 0 0 -1 -1 -2 -1
Cash Fr. Finan. 0 1 1 1 0
Net Change 0 0 1 -1 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 1 0 0 0 0 1 0 0

Desh Rakshak Aushdhalaya Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 64.28 64.28 64.28 64.28 64.28 64.28 64.28 64.28 64.28
Public 35.72 35.72 35.72 35.72 35.72 35.72 35.72 35.72 35.72
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Desh Rakshak Aushdhalaya Ltd. Announcements

Mon, 22 Apr 2024
Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31.03.2024
This is for your reference we herein provide the Compliance Certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 for the financial year ended on 31.03.2024
Wed, 10 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pursuant to Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 we are enclosing herewith certificate issued by MAS Services Limited Registrar and Share Transfer Agent of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2024
Fri, 05 Apr 2024
Disclosure Under Regulation 31(4) Of Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations 2011
Please Find enclosed the yearly disclosure under Regulation 31(4) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended for the financial year ended March 31 2024

Desh Rakshak Aushdhalaya Ltd. Technical Scans

No Scans Found

Desh Rakshak Aushdhalaya Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,484.65 -3.6%
Cipla Ltd. 108,812.62 1,346.70 -0.6%
Divi's Laboratories Ltd. 100,075.02 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,952.10 -1.1%
Zydus Lifesciences Ltd. 96,553.18 959.45 0.0%
Mankind Pharma Ltd. 95,896.87 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. 89,224.37 2,637.40 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.34 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,637.40 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.20 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,637.40 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,637.40 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,637.40 +1.8%

Desh Rakshak Aushdhalaya Ltd. FAQ's

What is Desh Rakshak Aushdh share price?

Can I buy Desh Rakshak Aushdh shares now?

What is the Market Cap of Desh Rakshak Aushdh?

What are the key metrics to analyse Desh Rakshak Aushdh?

What is the 52 Week High and Low of Desh Rakshak Aushdh?